Lupin Digital Health (LDH), India's premier cardiac digital medicines firm, has announced the establishment of Lyfe Digital Heart Failure Clinic in India. This ground-breaking e-clinic intends to assist cardiologists...
The Central Drugs Standard Control Organisation (CDSCO) has begun training Medical Device Officers from Gujarat and Maharashtra Food and Drug Administration for the proper implementation of the new Medical Device Rules (MDR)-2017...
Biosense Webster, Inc., a global pioneer in cardiac arrhythmia treatment and a subsidiary of Johnson & Johnson MedTech, announced that the US Food and Drug Administration (FDA) has approved various products in its market-leading cardiac ablation...
The Uttar Pradesh government has issued the Pharmaceutical and Medical Devices Industry Policy, 2023, which includes provisions for a single window clearance under the direct supervision of the Chief Minister's office, time-bound clearances,...
Finding new indications for current medications or potential therapeutic candidates is known as drug repurposing. Opportunities for drug repositioning might come through indirect observation as well as intentional collaboration.
Dr. Mansukh Mandaviya, Union Minister for Health and Family Welfare, announced on Thursday that India has tripled its rate of organ donation in the last decade...
Pharmaceutical pellets are designed to release the medication slowly over a period of time, allowing for a more controlled and sustained release of the drug into the body. This method of delivery is particularly beneficial for medications that req...
The Indian pharmaceutical industry is now looking for talent in regulatory departments, as vacancies at the mid and senior levels continue to be a challenge. The workforce here is responsible for managing the protocols required to submit newer...
Granules India Limited, a vertically integrated and rapidly growing Indian pharmaceutical company, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company based in Chantilly, Virginia, USA,....
Later this week, Zydus Lifesciences Ltd announced that it has gained final permission from the US Food and Drug Administration to manufacture and market its generic Indomethacin suppositories for moderate to severe rheumatoid arthritis...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")